Acceleron Pharma, Inc.: Series D $30.4M

Posted in I - Series D, Q - 4Q11, R - NORTH EAST, X - Anemia, X - Muscular Dystrophy, X - Oncology, X - Osteoporosis, XX - MA

Acceleron Pharma (Cambridge, MA) is a clinical-stage biopharmaceutical company focused on protein therapeutics for anemia, cancer, Duchenne Muscular Dystrophy and bone loss diseases, closed a $30.4M Series D financing. Participants have included Advanced Technology Ventures, Avalon Ventures, Bessemer Venture Partners, Celgene, Flagship Ventures, MPM Capital, Orbimed, Polaris Ventures, QVT Financial, Sutter Hill Ventures and Venrock.

Jul

2011

Radius Health, Inc.: Series C $66M

Posted in I - Series C, Q - 2Q11, R - NORTH EAST, X - Osteoporosis, XX - MA

Radius Health (Cambridge, MA) a clinical-stage biopharmaceutical company focused on osteoporosis and women’s health, closed a $66M Series C financing. Participants include Brookside Capital, Saints Capital, Nordic Bioscience, Ipsen Pharma, MPM Capital, BB Biotech Ventures, The Wellcome Trust, HealthCare Ventures and Scottish Widows Investment Partnership.

Jan

2010

Tarsa Therapeutics, Inc.: Series A $24M

Posted in I - Series A, Q - 4Q09, R - NORTH EAST, X - Osteoporosis, XX - NJ

Tarsa Therapeutics (Boonton, NJ) a clinical stage small molecule company focused on osteoporosis closed a $24M Series A financing. Participants include MVM Life Science Partners, Quaker BioVentures and Novo Ventures.

Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb.

Aug

2009

Zosano Pharma, Inc.: Series B $30M

Posted in I - Series B, Q - 3Q09, R - WEST, X - Device (Delivery), X - Influenza, X - Osteoporosis, XX - CA

Zosano Pharma (Fremont, CA) a clinical-stage device company focused on a transdermal microprojection delivery system for needle-free administration therapeutic peptides, small molecules and vaccines. Participants include Nomura Phase4 Ventures, New Enterprise Associates, HBM BioVentures and ProQuest Investments.

Dec

2008

Radius Health, Inc.: Series C $82.5M

Posted in I - Series C, Q - 4Q08, R - NORTH EAST, X - Endometriosis, X - Osteoporosis

Radius Health (Cambridge, MA) early-stage company focused on development of therapeutics for osteoporosis and women’s health, closed a $82.5M Series C financing. Participants include MPM Capital, The Wellcome Trust, HealthCare Ventures, Oxford Bioscience Partners, BB Biotech Ventures and Scottish Widows Investment Partnership.

to top of page...